Unknown

Dataset Information

0

Uncommon low-grade brain tumors.


ABSTRACT: The 2016 World Health Organization (WHO) classification of primary central nervous system (CNS) tumors includes numerous uncommon (representing ?1% of tumors) low-grade (grades I-II) brain neoplasms with varying clinical behaviors and outcomes. Generally, gross tumor or maximal safe resection is the primary treatment. Adjuvant treatments, though their exact role is unknown, may be considered individually based on pathological subtypes and a proper assessment of risks and benefits. Targetable mutations such as BRAF (proto-oncogene B-Raf), TRAIL (tumor necrosis factor apoptosis inducing ligand), and PDGFR (platelet derived growth factor receptor) have promising roles in future management.

SUBMITTER: Ajithkumar T 

PROVIDER: S-EPMC6374757 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications


The 2016 World Health Organization (WHO) classification of primary central nervous system (CNS) tumors includes numerous uncommon (representing ≤1% of tumors) low-grade (grades I-II) brain neoplasms with varying clinical behaviors and outcomes. Generally, gross tumor or maximal safe resection is the primary treatment. Adjuvant treatments, though their exact role is unknown, may be considered individually based on pathological subtypes and a proper assessment of risks and benefits. Targetable mut  ...[more]

Similar Datasets

2019-03-18 | GSE94976 | GEO
| S-EPMC4866893 | biostudies-literature
| PRJNA374999 | ENA
| S-EPMC3775342 | biostudies-literature
| S-EPMC4000396 | biostudies-other
| S-EPMC5596318 | biostudies-literature
| S-EPMC5003665 | biostudies-literature
| S-EPMC7035775 | biostudies-literature
| S-EPMC3462659 | biostudies-literature
| S-EPMC5939705 | biostudies-literature